D-207-2013 Class III Terminated
FDA drug recall D-207-2013 was initiated by Novartis Consumer Health on Mar 7, 2013 and is designated Class III. Reason for recall: Labeling: Incorrect or Missing Lot and/or Exp Date. The lot number and/or expiration date may be illegible. The recall status is terminated (terminated Nov 26, 2014). Affected quantity: 240,120/2-oz. tubes and 429,144/4-oz. tubes.
Recall details
- Product Type
- Drugs
- Report Date
- Mar 27, 2013
- Initiation Date
- Mar 7, 2013
- Termination Date
- Nov 26, 2014
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 240,120/2-oz. tubes and 429,144/4-oz. tubes
Product description
Myoflex (trolamine salicylate) 10%, Pain Relieving Cream, a) 2-oz tube, b) 4-oz. tube, OTC. The firm name on the label is Novartis Consumer Health, Inc., Parsippany, NJ 07054.
Reason for recall
Labeling: Incorrect or Missing Lot and/or Exp Date. The lot number and/or expiration date may be illegible.
Distribution pattern
Nationwide and Panama
Code information
Lot #: a) 10086783, 10088745, 10088746, 10090537, 10093867, 10093868, 10098162, 10098541, 10098542, 10102311, 10109145, 10109146, 10120111, 10122759, and 10122760, Exp 3/13 to 9/14; b) 10086785, 10088747, 10088748, 10090538, 10093869, 10093870, 10098160, 10098161, 10098540, 10099841, 10104146, 10109143, 10109144, 10111501, 10115614, 10120112, 10121759, 10122698, 10122757, and 10122758, Exp 3/13 to 10/14.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-207-2013
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026